Gastrointestional

COLON/RECTAL

PREVENTION

  • SWOG S0820– A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage O-III Colon Cancer Phase III- Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

NEOADJUVANT

  • NCCTG N1048– Phase II/III Randomized Study of Neoadjuvant FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Chemoradiation Comprising Fluorouracil or Capecitabine, and Radiation Therapy in Patients With Locally Advanced Rectal Cancer Undergoing Low-Anterior Resection With Total Mesorectal Excision

Metastatic

  • SWOG S1417CD– Implementation of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer

Radiation

  • RTOG 0631– A Randomized Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis